Zimmer Biomet Holdings Company Profile (NYSE:ZBH)

About Zimmer Biomet Holdings (NYSE:ZBH)

Zimmer Biomet Holdings logoZimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Symbol: NYSE:ZBH
  • CUSIP: N/A
  • Web: www.zimmerbiomet.com
  • Market Cap: $24.4 billion
  • Outstanding Shares: 202,195,000
Average Prices:
  • 50 Day Moving Avg: $116.07
  • 200 Day Moving Avg: $120.38
  • 52 Week Range: $95.63 - $133.49
  • Trailing P/E Ratio: 34.21
  • Foreward P/E Ratio: 13.78
  • P/E Growth: 1.77
Sales & Book Value:
  • Annual Revenue: $7.78 billion
  • Price / Sales: 3.14
  • Book Value: $50.86 per share
  • Price / Book: 2.37
  • Annual Dividend: $0.96
  • Dividend Yield: 0.8%
  • EBITDA: $2.8 billion
  • Net Margins: 9.12%
  • Return on Equity: 16.70%
  • Return on Assets: 6.18%
  • Debt-to-Equity Ratio: 0.91%
  • Current Ratio: 1.48%
  • Quick Ratio: 0.80%
  • Average Volume: 1.35 million shs.
  • Beta: 1.19
  • Short Ratio: 3.17

Frequently Asked Questions for Zimmer Biomet Holdings (NYSE:ZBH)

What is Zimmer Biomet Holdings' stock symbol?

Zimmer Biomet Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

How often does Zimmer Biomet Holdings pay dividends? What is the dividend yield for Zimmer Biomet Holdings?

Zimmer Biomet Holdings declared a quarterly dividend on Monday, August 7th. Investors of record on Friday, September 22nd will be given a dividend of $0.24 per share on Friday, October 27th. This represents a $0.96 dividend on an annualized basis and a yield of 0.80%. The ex-dividend date of this dividend is Thursday, September 21st. View Zimmer Biomet Holdings' Dividend History.

How were Zimmer Biomet Holdings' earnings last quarter?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) released its quarterly earnings data on Thursday, July, 27th. The company reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.10 by $0.02. The business had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The company's revenue was up 1.1% on a year-over-year basis. During the same period in the previous year, the company posted $2.02 EPS. View Zimmer Biomet Holdings' Earnings History.

When will Zimmer Biomet Holdings make its next earnings announcement?

Zimmer Biomet Holdings is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Zimmer Biomet Holdings.

What guidance has Zimmer Biomet Holdings issued on next quarter's earnings?

Zimmer Biomet Holdings issued an update on its FY17 earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $8.20-8.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.51. The company issued revenue guidance of $7.8-7.87 billion, compared to the consensus revenue estimate of $7.86 billion.Zimmer Biomet Holdings also updated its Q3 guidance to $1.72-1.77 EPS.

Where is Zimmer Biomet Holdings' stock going? Where will Zimmer Biomet Holdings' stock price be in 2017?

21 equities research analysts have issued 1-year target prices for Zimmer Biomet Holdings' shares. Their predictions range from $92.00 to $158.00. On average, they anticipate Zimmer Biomet Holdings' stock price to reach $138.47 in the next year. View Analyst Ratings for Zimmer Biomet Holdings.

What are analysts saying about Zimmer Biomet Holdings stock?

Here are some recent quotes from research analysts about Zimmer Biomet Holdings stock:

  • 1. According to Zacks Investment Research, "Zimmer Biomet has been lagging the broader industry with respect to share price movement over the last three months. Zimmer Biomet ended the second quarter on a mixed note. While earnings topped the estimate, revenues remained in line with the same. We are disappointed by the company's declining sales performance within several of its core segments. Moreover, the market seems to be apprehensive about the departure of Zimmer’s decade old CEO David C. Dvorak. The trimmed 2017 guidance adds to our concerns indicating little chances of recovery ahead. Nevertheless, improved gross and operating margin performance was encouraging. We look forward to the expected synergy from the LDR Holding acquisition, which should broaden and complement the company's musculoskeletal offering. We are also impressed by the strong strategic and financial goals which the combined entity expects to reach, now that the deal has been closed." (9/26/2017)
  • 2. Canaccord Genuity analysts commented, "SGEN reported 1Q earnings and provided a pipeline update." (4/28/2017)
  • 3. Needham & Company LLC analysts commented, "We hosted a dinner and investor meetings with Dan Florin, Senior Vice President and CFO, and Bob Marshall, Treasurer and Vice President of Investor Relations this week in New York City. We think that the discussion was upbeat and highlighted ZBH's progress in addressing its manufacturing challenges, its non-recon business performance, margin opportunities, and cash flow outlook. The meetings reinforced our view that ZBH should be able to drive its revenue growth to sustainable mid-single digit growth with a combination of market growth in recon and above-market growth in its non-recon businesses. We reiterate our Strong Buy rating." (2/17/2017)

Who are some of Zimmer Biomet Holdings' key competitors?

Who are Zimmer Biomet Holdings' key executives?

Zimmer Biomet Holdings' management team includes the folowing people:

  • Daniel P. Florin, Interim Chief Executive Officer, Chief Financial Officer, Director
  • Robert D. Delps, President, Americas
  • Katarzyna Mazur-Hofsaess M.D. Ph.D., President, Europe, Middle East and Africa
  • Sang Yi, President, Asia Pacific
  • Chad F. Phipps, Senior Vice President, General Counsel, Secretary
  • Larry C. Glasscock, Independent Non-Executive Chairman of the Board
  • Christopher B. Begley, Independent Director
  • Betsy J. Bernard, Independent Director
  • Gail Koziara Boudreaux, Independent Director
  • Michael Farrell, Independent Director

Who owns Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Curbstone Financial Management Corp (0.00%). Company insiders that own Zimmer Biomet Holdings stock include Blackstone Capital Partners V, Chad F Phipps, Daniel E Williamson, Daniel P Florin, David A Jr Nolan, David C Dvorak, Sang Yi, Stuart G Kleopfer and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet Holdings.

Who bought Zimmer Biomet Holdings stock? Who is buying Zimmer Biomet Holdings stock?

Zimmer Biomet Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Curbstone Financial Management Corp. View Insider Buying and Selling for Zimmer Biomet Holdings.

How do I buy Zimmer Biomet Holdings stock?

Shares of Zimmer Biomet Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zimmer Biomet Holdings' stock price today?

One share of Zimmer Biomet Holdings stock can currently be purchased for approximately $120.69.

MarketBeat Community Rating for Zimmer Biomet Holdings (NYSE ZBH)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  545 (Vote Outperform)
Underperform Votes:  414 (Vote Underperform)
Total Votes:  959
MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Zimmer Biomet Holdings (NYSE:ZBH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 13 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $138.47 (14.74% upside)
Consensus Price Target History for Zimmer Biomet Holdings (NYSE:ZBH)
Price Target History for Zimmer Biomet Holdings (NYSE:ZBH)
Analysts' Ratings History for Zimmer Biomet Holdings (NYSE:ZBH)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/2/2017SunTrust Banks, Inc.Reiterated RatingBuy$136.00LowView Rating Details
8/24/2017GabelliInitiated CoverageBuy$142.00LowView Rating Details
8/14/2017Oppenheimer Holdings, Inc.Set Price TargetBuy$137.00LowView Rating Details
7/28/2017BMO Capital MarketsBoost Price TargetOutperform$136.00 -> $140.00LowView Rating Details
7/28/2017Leerink SwannBoost Price TargetOutperform$141.00 -> $146.00LowView Rating Details
7/28/2017Piper Jaffray CompaniesReiterated RatingBuy$135.00MediumView Rating Details
7/28/2017Canaccord GenuityDowngradeBuy -> Hold$141.00 -> $135.00MediumView Rating Details
7/27/2017Cantor FitzgeraldSet Price TargetHold$137.00LowView Rating Details
7/17/2017Morgan StanleyBoost Price TargetOverweight$137.00 -> $150.00LowView Rating Details
7/14/2017Stifel NicolausReiterated RatingHold$125.00LowView Rating Details
7/14/2017Bank of America CorporationReiterated RatingBuy -> Buy$158.00MediumView Rating Details
7/14/2017Wells Fargo & CompanyReiterated RatingMarket WeightHighView Rating Details
7/14/2017Royal Bank Of CanadaReiterated RatingOutperform$140.00HighView Rating Details
7/12/2017Needham & Company LLCReiterated RatingStrong-Buy$153.00LowView Rating Details
7/12/2017GuggenheimUpgradeNeutral -> Buy$157.00MediumView Rating Details
6/30/2017Jefferies Group LLCReiterated RatingBuy$148.00LowView Rating Details
6/9/2017Citigroup Inc.Boost Price TargetNeutral$108.00 -> $130.00LowView Rating Details
5/16/2017Goldman Sachs Group, Inc. (The)Initiated CoverageSell -> Sell$92.00HighView Rating Details
2/1/2017Robert W. BairdReiterated RatingOutperform$130.00 -> $136.00N/AView Rating Details
1/5/2017J P Morgan Chase & CoSet Price TargetBuy$134.00N/AView Rating Details
11/8/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/22/2016ArgusReiterated RatingBuy$140.00N/AView Rating Details
8/23/2016Barclays PLCBoost Price TargetOverweight$140.00 -> $145.00N/AView Rating Details
7/29/2016JMP SecuritiesBoost Price TargetMarket Outperform$131.00 -> $145.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$123.00N/AView Rating Details
1/31/2016William BlairReiterated RatingOutperformN/AView Rating Details
1/29/2016Northland SecuritiesLower Price Target$109.00 -> $105.00N/AView Rating Details
10/30/2015Brean CapitalReiterated RatingHoldN/AView Rating Details
(Data available from 10/19/2015 forward)


Earnings History for Zimmer Biomet Holdings (NYSE:ZBH)
Earnings by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Earnings History by Quarter for Zimmer Biomet Holdings (NYSE ZBH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017$1.83N/AView Earnings Details
7/27/2017Q2 2017$2.10$2.08$1.95 billion$1.95 billionViewN/AView Earnings Details
4/27/2017Q1 2017$2.11$2.13$1.96 billion$1.98 billionViewN/AView Earnings Details
1/31/2017Q416$2.11$2.14$1.98 billion$2.01 billionViewListenView Earnings Details
10/31/2016Q316$1.79$1.79$950.20 million$1.83 billionViewListenView Earnings Details
7/28/2016Q216$1.97$2.02$1.90 billion$1.93 billionViewListenView Earnings Details
4/28/2016Q116$1.93$2.00$1.88 billion$1.90 billionViewListenView Earnings Details
1/28/2016Q415$2.04$2.09$1.96 billion$1.98 billionViewListenView Earnings Details
10/29/2015Q315$1.56$1.64$1.76 billion$1.76 billionViewListenView Earnings Details
4/30/2015Q115$1.54$1.58$1.15 billion$1.13 billionViewN/AView Earnings Details
1/29/2015Q414$1.71$0.91$1.25 billion$1.22 billionViewN/AView Earnings Details
10/23/2014Q314$1.00$0.96$1.10 billion$1.11 billionViewListenView Earnings Details
7/24/2014Q214$1.49$1.49$1.21 billion$1.18 billionViewN/AView Earnings Details
4/24/2014Q114$1.47$1.50$1.18 billion$1.16 billionViewListenView Earnings Details
1/31/2014Q114$1.62$1.36$1.22 billion$1.24 billionViewN/AView Earnings Details
10/24/2013Q313$1.24$1.25$1.06 billion$1.07 billionViewN/AView Earnings Details
7/25/2013Q2 2013$1.44$1.43$1.15 billion$1.17 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.40$1.41$1.14 billion$1.14 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.49$1.51$1.17 billion$1.18 billionViewN/AView Earnings Details
10/25/2012$1.13$1.15ViewN/AView Earnings Details
7/26/2012$1.32$1.34ViewN/AView Earnings Details
4/26/2012$1.30$1.30ViewN/AView Earnings Details
1/26/2012$1.34$1.36ViewN/AView Earnings Details
10/27/2011$1.03$1.04ViewN/AView Earnings Details
7/27/2011$1.19$1.21ViewN/AView Earnings Details
4/28/2011$1.12$1.19ViewN/AView Earnings Details
1/27/2011$1.19$1.21ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Zimmer Biomet Holdings (NYSE:ZBH)
2017 EPS Consensus Estimate: $8.31
2018 EPS Consensus Estimate: $9.11
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$2.10$2.14$2.11
Q2 20176$2.08$2.18$2.12
Q3 20176$1.71$1.93$1.77
Q4 20176$2.26$2.41$2.31
Q1 20183$2.18$2.32$2.27
Q2 20183$2.17$2.39$2.26
Q3 20182$1.92$2.18$2.05
Q4 20182$2.46$2.59$2.53
(Data provided by Zacks Investment Research)


Current Dividend Information for Zimmer Biomet Holdings (NYSE:ZBH)
Next Dividend:10/27/2017
Annual Dividend:$0.96
Dividend Yield:0.80%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:27.59% (Trailing 12 Months of Earnings)
11.66% (Based on This Year's Estimates)
10.96% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Dividend History by Quarter for Zimmer Biomet Holdings (NYSE ZBH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Zimmer Biomet Holdings (NYSE:ZBH)
Insider Ownership Percentage: 1.07%
Institutional Ownership Percentage: 85.22%
Insider Trades by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Insider Trades by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/31/2017Tony W. CollinsVPSell16,986$121.74$2,067,875.64View SEC Filing  
6/12/2017Sang YiInsiderSell17,731$124.56$2,208,573.36View SEC Filing  
5/5/2017Chad F. PhippsVPSell6,200$116.76$723,912.00View SEC Filing  
4/27/2017David C DvorakInsiderSell87,331$116.47$10,171,441.57View SEC Filing  
3/20/2017David C DvorakInsiderSell1,040$121.63$126,495.20View SEC Filing  
12/2/2016David A. Jr. NolanInsiderSell5,050$101.11$510,605.50View SEC Filing  
9/8/2016Daniel E WilliamsonInsiderSell2,716$129.96$352,971.36View SEC Filing  
8/23/2016Stuart G KleopferInsiderSell3,397$129.71$440,624.87View SEC Filing  
8/12/2016Tony W. CollinsVPSell1,287$129.16$166,228.92View SEC Filing  
8/9/2016Stuart G KleopferInsiderSell533$132.71$70,734.43View SEC Filing  
8/1/2016David A. Jr. NolanInsiderSell25,255$130.77$3,302,596.35View SEC Filing  
7/11/2016Daniel P FlorinCFOSell15,000$124.98$1,874,700.00View SEC Filing  
6/14/2016Tony W CollinsCAOSell3,611$116.43$420,428.73View SEC Filing  
6/9/2016Stuart G KleopferInsiderSell11,000$119.45$1,313,950.00View SEC Filing  
4/14/2016Daniel P FlorinCFOSell10,000$114.98$1,149,800.00View SEC Filing  
4/12/2016Daniel P FlorinCFOSell12,000$110.00$1,320,000.00View SEC Filing  
3/21/2016David C DvorakCEOSell1,540$104.16$160,406.40View SEC Filing  
2/10/2016Blackstone Capital Partners VMajor ShareholderSell7,351,708$95.91$705,102,314.28View SEC Filing  
1/8/2016David C. DvorakCEOSell44,661$102.46$4,575,966.06View SEC Filing  
12/2/2015David A. Jr. NolaninsiderSell3,435$102.62$352,499.70View SEC Filing  
6/30/2015Adam Rudolph JohnsonInsiderSell30,600$110.34$3,376,404.00View SEC Filing  
6/29/2015Daniel E WilliamsonInsiderSell16,000$110.98$1,775,680.00View SEC Filing  
6/29/2015Daniel P FlorinCFOSell5,000$107.00$535,000.00View SEC Filing  
3/17/2015David C DvorakCEOSell1,300$115.55$150,215.00View SEC Filing  
12/5/2014David C DvorakCEOSell48,703$115.00$5,600,845.00View SEC Filing  
11/28/2014Chad F PhippsVPSell5,000$112.00$560,000.00View SEC Filing  
11/3/2014Katarzyna Mazur-HofsaessInsiderSell28,253$110.01$3,108,112.53View SEC Filing  
9/9/2014Stephen Hong Liang OoiInsiderSell40,768$102.78$4,190,135.04View SEC Filing  
8/26/2014James T CrinesCFOSell40,768$101.00$4,117,568.00View SEC Filing  
1/8/2014Jeffery MccaulleyInsiderSell21,286$96.00$2,043,456.00View SEC Filing  
1/7/2014Chad PhippsVPSell7,000$95.00$665,000.00View SEC Filing  
12/20/2013Jeffery MccaulleyInsiderSell21,286$93.00$1,979,598.00View SEC Filing  
12/3/2013Jeffery MccaulleyInsiderSell2,713$90.12$244,495.56View SEC Filing  
11/15/2013Derek DavisCAOSell3,500$90.20$315,700.00View SEC Filing  
11/14/2013Chad PhippsVPSell7,800$90.00$702,000.00View SEC Filing  
11/14/2013David DvorakCEOSell64,763$90.00$5,828,670.00View SEC Filing  
11/14/2013Jeffery MccaulleyInsiderSell21,285$90.00$1,915,650.00View SEC Filing  
9/13/2013Katarzyna Mazur-HofsaessInsiderSell4,890$81.38$397,948.20View SEC Filing  
8/1/2013James T CrinesCFOSell46,200$84.56$3,906,672.00View SEC Filing  
8/1/2013Stephen Hong Liang OoiInsiderSell38,500$84.27$3,244,395.00View SEC Filing  
7/29/2013Derek M DavisCAOSell3,725$83.78$312,080.50View SEC Filing  
7/29/2013Jeffery A MccaulleyInsiderSell112,255$83.40$9,362,067.00View SEC Filing  
7/19/2013Chad F PhippsVPSell6,000$83.00$498,000.00View SEC Filing  
5/8/2013Chad F PhippsVPSell5,000$77.26$386,300.00View SEC Filing  
4/30/2013James T CrinesCFOSell25,000$76.08$1,902,000.00View SEC Filing  
4/30/2013Jeffery A MccaulleyInsiderSell10,000$76.08$760,800.00View SEC Filing  
2/4/2013Derek M DavisCAOSell21,864$72.53$1,585,795.92View SEC Filing  
2/4/2013Jeffery A MccaulleyInsiderSell12,000$73.60$883,200.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Zimmer Biomet Holdings (NYSE:ZBH)
Latest Headlines for Zimmer Biomet Holdings (NYSE:ZBH)
americanbankingnews.com logoFY2017 EPS Estimates for Zimmer Biomet Holdings, Inc. (ZBH) Increased by Analyst
www.americanbankingnews.com - October 18 at 8:58 AM
investorplace.com logoZimmer Biomet Holdings, Inc. (ZBH) a Sell on Lousy Earnings Growth
investorplace.com - October 17 at 12:08 PM
americanbankingnews.com logoNorthcoast Research Weighs in on Zimmer Biomet Holdings, Inc.'s Q3 2017 Earnings (ZBH)
www.americanbankingnews.com - October 17 at 6:08 AM
americanbankingnews.com logo$1.75 Earnings Per Share Expected for Zimmer Biomet Holdings, Inc. (ZBH) This Quarter
www.americanbankingnews.com - October 16 at 12:30 PM
seekingalpha.com logoWright Can't Get It Right
seekingalpha.com - October 13 at 10:36 AM
americanbankingnews.com logoZimmer Biomet Holdings, Inc. (ZBH) to Post Q3 2017 Earnings of $1.72 Per Share, Leerink Swann Forecasts
www.americanbankingnews.com - October 13 at 5:52 AM
investorplace.com logoStock of Zimmer Biomet Holdings, Inc. (ZBH) Ranked a Sell
investorplace.com - October 10 at 12:32 PM
finance.yahoo.com logoETFs with exposure to Zimmer Biomet Holdings, Inc. : October 9, 2017
finance.yahoo.com - October 10 at 8:38 AM
finance.yahoo.com logoZimmer Biomet Holdings Announces Audio Webcast and Conference Call of Third Quarter 2017 Results
finance.yahoo.com - October 10 at 8:38 AM
nasdaq.com logoZimmer Biomet Holdings Breaks Above 200-Day Moving Average - Bullish for ZBH - Nasdaq
www.nasdaq.com - October 6 at 3:35 PM
americanbankingnews.com logoCritical Review: Cardiovascular Systems (CSII) & Zimmer Biomet Holdings (ZBH)
www.americanbankingnews.com - October 5 at 12:18 PM
finance.yahoo.com logoZimmer Biomet Announces U.S. Launch of Avenue® T TLIF Cage with Integrated VerteBRIDGE® Plating
finance.yahoo.com - October 4 at 6:06 PM
nasdaq.com logoSmith & Nephew SNATS, Inc. (SNN) Ex-Dividend Date Scheduled for October 05, 2017 - Nasdaq
www.nasdaq.com - October 4 at 1:04 PM
nasdaq.com logoInvacare Corporation (IVC) Ex-Dividend Date Scheduled for October 04, 2017 - Nasdaq
www.nasdaq.com - October 3 at 4:28 PM
streetinsider.com logoZimmer Biomet Holdings (ZBH) Launches Avenue T TLIF Cage with Integrated VerteBRIDGE Plating in US - StreetInsider.com
www.streetinsider.com - October 3 at 4:28 PM
bizjournals.com logoGlobal spine implant company takes root in new Westminster HQ - Denver Business Journal
www.bizjournals.com - September 29 at 5:22 PM
zacks.com logoNuVasive Acquires Vetera Spine, Grows With Spinal Hardware
www.zacks.com - September 28 at 12:35 PM
americanbankingnews.com logoZimmer Biomet Holdings, Inc. (ZBH) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - September 27 at 6:40 AM
finance.yahoo.com logoZBH’s Persona Partial Knee Launch Expands Knee Implant Portfolio
finance.yahoo.com - September 23 at 12:55 PM
finance.yahoo.com logoWhy Most Analysts Recommend a ‘Buy’ on ZBH Stock
finance.yahoo.com - September 23 at 12:55 PM
finance.yahoo.com logoHow Is ZBH’s Spine Business Positioned a Year after LDRH Acquisition?
finance.yahoo.com - September 23 at 12:55 PM
finance.yahoo.com logoHow Does ZBH Plan to Revive Growth Momentum in Dental Business?
finance.yahoo.com - September 23 at 12:55 PM
finance.yahoo.com logoHow Has ZBH Stock Performed Recently?
finance.yahoo.com - September 23 at 12:55 PM
americanbankingnews.com logoComparing Zimmer Biomet Holdings (ZBH) and Its Competitors
www.americanbankingnews.com - September 19 at 8:10 PM
nasdaq.com logoZimmer Biomet (ZBH) Launches Persona Partial Knee System - Nasdaq
www.nasdaq.com - September 12 at 3:37 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Zimmer Biomet Holdings Inc.
finance.yahoo.com - September 12 at 12:34 PM
finance.yahoo.com logoZimmer Biomet (ZBH) Launches Persona Partial Knee System
finance.yahoo.com - September 12 at 12:34 PM
americanbankingnews.com logoFinancial Analysis: Zimmer Biomet Holdings (ZBH) vs. The Competition
www.americanbankingnews.com - September 11 at 2:24 AM
finance.yahoo.com logoNuVasive Announces Vertera Spine Buyout, Boosts Implants Suite
finance.yahoo.com - September 8 at 10:53 AM
finance.yahoo.com logoZimmer Biomet Holdings to Present at Morgan Stanley 15th Annual Global Healthcare Conference
finance.yahoo.com - September 7 at 11:41 AM
americanbankingnews.com logoZimmer Biomet Holdings, Inc. (ZBH) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 2 at 6:32 AM
seekingalpha.com logoZimmer Biomet Holdings: Undervalued And Unloved - Seeking Alpha
seekingalpha.com - September 1 at 11:43 AM
finance.yahoo.com logoWhat Zimmer Biomet’s Leadership Transition Could Mean for Its Core Growth Strategy
finance.yahoo.com - September 1 at 11:43 AM
finance.yahoo.com logoWhy Zimmer Biomet Made Another Downward Revision to Its Fiscal 2017 Guidance
finance.yahoo.com - September 1 at 11:43 AM
finance.yahoo.com logoInside Zimmer Biomet’s Latest Dividend Announcement
finance.yahoo.com - September 1 at 11:43 AM
finance.yahoo.com logoWhich Way Are Zimmer Biomet’s Analysts Leaning after 2Q17?
finance.yahoo.com - September 1 at 11:43 AM
finance.yahoo.com logoWhat’s Behind the Recent Slump in ZBH Stock Price?
finance.yahoo.com - September 1 at 11:43 AM
finance.yahoo.com logoBehind Zimmer Biomet’s 2Q17 Revenue Fall
finance.yahoo.com - August 31 at 11:44 AM
seekingalpha.com logoZimmer Biomet Needs An Experienced Leader - Seeking Alpha
seekingalpha.com - August 30 at 11:36 AM
americanbankingnews.com logoAnalyzing Inogen (INGN) and Zimmer Biomet Holdings (ZBH)
www.americanbankingnews.com - August 29 at 8:06 PM
americanbankingnews.com logoGabelli Comments on Zimmer Biomet Holdings, Inc.'s FY2017 Earnings (ZBH)
www.americanbankingnews.com - August 28 at 2:02 AM
americanbankingnews.com logoGabelli Comments on Zimmer Biomet Holdings, Inc.'s FY2019 Earnings (ZBH)
www.americanbankingnews.com - August 25 at 2:44 PM
americanbankingnews.com logoZimmer Biomet Holdings, Inc. (ZBH) Now Covered by Analysts at Gabelli
www.americanbankingnews.com - August 24 at 2:48 PM
americanbankingnews.com logoZimmer Biomet Holdings, Inc. (ZBH) Expected to Post Quarterly Sales of $1.83 Billion
www.americanbankingnews.com - August 23 at 10:50 AM
americanbankingnews.com logoReviewing Zimmer Biomet Holdings (NYSE:ZBH) and CryoLife (CRY)
www.americanbankingnews.com - August 14 at 8:06 PM
finance.yahoo.com logoNew Strong Sell Stocks for August 14th
finance.yahoo.com - August 14 at 8:38 AM
finance.yahoo.com logoZimmer Biomet Holdings, Inc. – Value Analysis (NYSE:ZBH) : August 12, 2017
finance.yahoo.com - August 12 at 9:04 AM
finance.yahoo.com logoZimmer Biomet Announces Quarterly Dividend for Third Quarter of 2017
finance.yahoo.com - August 8 at 8:33 AM
americanbankingnews.com logoZimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 8 at 7:46 AM
americanbankingnews.com logoZimmer Biomet Holdings, Inc. Plans Quarterly Dividend of $0.24 (ZBH)
www.americanbankingnews.com - August 7 at 6:34 PM



Zimmer Biomet Holdings (ZBH) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.